Atlas Trials

Phase II Study of TAS-106 to Treat Head and Neck Cancer

Clinical trial NCT00737360 · TERMINATED

Trial details

NCT number
NCT00737360
Sponsor
Taiho Pharmaceutical Co., Ltd.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Head and Neck Cancer
Start date
2008-08-01
Primary completion
2011-06-01
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.